Macrophages, Nitric Oxide and microRNAs Are Associated with DNA Damage Response Pathway and Senescence in Inflammatory Bowel Disease

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Sohn, Jane J ^a   Schetter, Aaron J ^a   Yfantis, Harris G ^b   Ridnour, Lisa A ^a   Horikawa, Izumi ^a   Khan, Mohammed A ^a   Robles, Ana I ^a   Hussain, S Perwez ^a   Goto, Akiteru ^a   Bowman, Elise D ^a   Hofseth, Lorne J ^c   Bartkova, Jirina ^d   Bartek, Jiri ^d,e   Wogan, Gerald N ^f   Wink, David A ^a   Harris, Curtis C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

^d DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^e PALACKÝ UNIVERSITY   (Czech Republic)

^f USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHECKPOINT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1; HISTONE GAMMA H2AX; HISTONE H2AX; INDUCIBLE NITRIC OXIDE SYNTHASE; MICRORNA; MICRORNA 21; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CELL AGING; CELL INFILTRATION; CELL TYPE; COCULTURE; COLON; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DNA DAMAGE; ENTERITIS; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SENESCENCE; ULCERATIVE COLITIS;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL AGING; CELLS, CULTURED; CHROMOSOMAL PROTEINS, NON-HISTONE; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; EPITHELIAL CELLS; FIBROBLASTS; HISTONES; HUMANS; INFLAMMATORY BOWEL DISEASES; MACROPHAGES; MICE; MICRORNAS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84866026484     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044156     Document Type: Article

References (70)

1. Loftus EV Jr, (2004) Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126: 1504-1517.
2. Ekbom A, Helmick C, Zack M, Adami HO, (1990) Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 323: 1228-1233.
3. Nair J, Gansauge F, Beger H, Dolara P, Winde G, et al. (2006) Increased etheno-DNA adducts in affected tissues of patients suffering from Crohn's disease, ulcerative colitis, and chronic pancreatitis. Antioxid Redox Signal 8: 1003-1010.
4. Hofseth LJ, Khan MA, Ambrose M, Nikolayeva O, Xu-Welliver M, et al. (2003) The adaptive imbalance in base excision-repair enzymes generates microsatellite instability in chronic inflammation. J Clin Invest 112: 1887-1894.
5. Hussain SP, Amstad P, Raja K, Ambs S, Nagashima M, et al. (2000) Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res 60: 3333-3337.
6. Salk JJ, Salipante SJ, Risques RA, Crispin DA, Li L, et al. (2009) Clonal expansions in ulcerative colitis identify patients with neoplasia. Proc Natl Acad Sci U S A.
7. Hofseth LJ, Saito S, Hussain SP, Espey MG, Miranda KM, et al. (2003) Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc Natl Acad Sci U S A 100: 143-148.
8. Ambs S, Bennett WP, Merriam WG, Ogunfusika MO, Oser SM, et al. (1999) Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer. J Natl Cancer Inst 91: 86-88.
9. Risques RA, Lai LA, Himmetoglu C, Ebaee A, Li L, et al. (2011) Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation. Cancer Res 71: 1669-1679. 0008-5472.CAN-10-1966 [pii];10.1158/0008-5472.CAN-10-1966 [doi].
10. Risques RA, Lai LA, Brentnall TA, Li L, Feng Z, et al. (2008) Ulcerative colitis is a disease of accelerated colon aging: evidence from telomere attrition and DNA damage. Gastroenterology 135: 410-418.
11. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, et al. (2005) DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434: 864-870.
12. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, et al. (2006) Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444: 633-637.
13. Jones CJ, Kipling D, Morris M, Hepburn P, Skinner J, et al. (2000) Evidence for a telomere-independent "clock" limiting RAS oncogene-driven proliferation of human thyroid epithelial cells. Mol Cell Biol 20: 5690-5699.
14. Campisi J, Yaswen P, (2009) Aging and cancer cell biology, 2009. Aging Cell 8: 221-225.
15. Binet R, Ythier D, Robles AI, Collado M, Larrieu D, et al. (2009) WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway. Cancer Res 69: 9183-9191.
16. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW, (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593-602.
17. Narita M, Nunez S, Heard E, Narita M, Lin AW, et al. (2003) Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113: 703-716. S009286740300401X [pii].
18. Xue W, Zender L, Miething C, Dickins RA, Hernando E, et al. (2007) Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445: 656-660.
19. Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, et al. (2002) A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109: 335-346.
20. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, et al. (2006) Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444: 638-642.
21. Rai P, Onder TT, Young JJ, McFaline JL, Pang B, et al. (2009) Continuous elimination of oxidized nucleotides is necessary to prevent rapid onset of cellular senescence. Proc Natl Acad Sci U S A 106: 169-174.
22. Favetta LA, Robert C, King WA, Betts DH, (2004) Expression profiles of p53 and p66shc during oxidative stress-induced senescence in fetal bovine fibroblasts. Exp Cell Res 299: 36-48.
23. Hussain SP, Harris CC, (2007) Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 121: 2373-2380.
24. Stewart B, Kleihues P (2003) The Causes of Cancer. In: World Cancer Report. Lyon: IARC Press. 56-61.
25. Prueitt RL, Boersma BJ, Howe TM, Goodman JE, Thomas DD, et al. (2007) Inflammation and IGF-I activate the Akt pathway in breast cancer. Int J Cancer 120: 796-805.
26. Mantovani A, Schioppa T, Porta C, Allavena P, Sica A, (2006) Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 25: 315-322.
27. Pollard JW, (2009) Trophic macrophages in development and disease. Nat Rev Immunol 9: 259-270.
28. Thomas DD, Ridnour LA, Isenberg JS, Flores-Santana W, Switzer CH, et al. (2008) The chemical biology of nitric oxide: implications in cellular signaling. Free Radic Biol Med 45: 18-31. S0891-5849(08)00175-5 [pii];10.1016/j.freeradbiomed.2008.03.020 [doi].
29. Thomas DD, Espey MG, Ridnour LA, Hofseth LJ, Mancardi D, et al. (2004) Hypoxic inducible factor 1alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide. Proc Natl Acad Sci U S A 101: 8894-8899.
30. Campisi J, Andersen JK, Kapahi P, Melov S (2011) Cellular senescence: A link between cancer and age-related degenerative disease? Semin Cancer Biol. S1044-579X(11)00050-2 [pii];10.1016/j.semcancer.2011.09.001 [doi].
31. Boersma BJ, Howe TM, Goodman JE, Yfantis HG, Lee DH, et al. (2006) Association of breast cancer outcome with status of p53 and MDM2 SNP309. J Natl Cancer Inst 98: 911-919.
32. Cox GW, Mathieson BJ, Gandino L, Blasi E, Radzioch D, et al. (1989) Heterogeneity of hematopoietic cells immortalized by v-myc/v-raf recombinant retrovirus infection of bone marrow or fetal liver. J Natl Cancer Inst 81: 1492-1496.
33. Dimri GP, Lee X, Basile G, Acosta M, Scott G, et al. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92: 9363-9367.
34. Kumamoto K, Spillare EA, Fujita K, Horikawa I, Yamashita T, et al. (2008) Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence. Cancer Res 68: 3193-3203.
35. Espey MG, Miranda KM, Pluta RM, Wink DA, (2000) Nitrosative capacity of macrophages is dependent on nitric-oxide synthase induction signals. J Biol Chem 275: 11341-11347.
36. Ridnour LA, Windhausen AN, Isenberg JS, Yeung N, Thomas DD, et al. (2007) Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and-independent pathways. Proc Natl Acad Sci U S A 104: 16898-16903. 0702761104 [pii];10.1073/pnas.0702761104 [doi].
37. Lundberg JO, Hellstrom PM, Lundberg JM, Alving K, (1994) Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 344: 1673-1674.
38. Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, et al. (2008) Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133: 1019-1031.
39. Fujita K, Mondal AM, Horikawa I, Nguyen GH, Kumamoto K, et al. (2009) p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence. Nat Cell Biol 11: 1135-1142.
40. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, et al. (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299: 425-436.
41. Schetter AJ, Nguyen GH, Bowman ED, Mathe EA, Yuen ST, et al. (2009) Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma. Clin Cancer Res 15: 5878-5887.
42. DePinho RA, (2000) The age of cancer. Nature 408: 248-254.
43. O'Sullivan JN, Bronner MP, Brentnall TA, Finley JC, Shen WT, et al. (2002) Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet 32: 280-284.
44. Risques RA, Lai LA, Himmetoglu C, Ebaee A, Li L, et al. (2011) Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation. Cancer Res 71: 1669-1679. 0008-5472.CAN-10-1966 [pii];10.1158/0008-5472.CAN-10-1966 [doi].
45. Campisi J, Andersen JK, Kapahi P, Melov S (2011) Cellular senescence: A link between cancer and age-related degenerative disease? Semin Cancer Biol. S1044-579X(11)00050-2 [pii];10.1016/j.semcancer.2011.09.001 [doi].
46. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM, (1998) DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273: 5858-5868.
47. Jackson SP, Bartek J, (2009) The DNA-damage response in human biology and disease. Nature 461: 1071-1078.
48. Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, et al. (2008) Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6: 2853-2868.
49. Connelly L, Jacobs AT, Palacios-Callender M, Moncada S, Hobbs AJ, (2003) Macrophage endothelial nitric-oxide synthase autoregulates cellular activation and pro-inflammatory protein expression. J Biol Chem 278: 26480-26487.
50. Thomas DD, Ridnour LA, Espey MG, Donzelli S, Ambs S, et al. (2006) Superoxide fluxes limit nitric oxide-induced signaling. J Biol Chem 281: 25984-25993.
51. Clemons NJ, McColl KE, Fitzgerald RC, (2007) Nitric oxide and acid induce double-strand DNA breaks in Barrett's esophagus carcinogenesis via distinct mechanisms. Gastroenterology 133: 1198-1209.
52. Dickey JS, Baird BJ, Redon CE, Sokolov MV, Sedelnikova OA, et al. (2009) Intercellular communication of cellular stress monitored by gamma-H2AX induction. Carcinogenesis 30: 1686-1695. bgp192 [pii];10.1093/carcin/bgp192 [doi].
53. Forrester K, Ambs S, Lupold SE, Kapust RB, Spillare EA, et al. (1996) Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc Natl Acad Sci U S A 93: 2442-2447.
54. Ambs S, Merriam WG, Ogunfusika MO, Bennett WP, Ishibe N, et al. (1998) p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells. Nat Med 4: 1371-1376.
55. Bhaumik D, Scott GK, Schokrpur S, Patil CK, Orjalo AV, et al. (2009) MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging (Albany NY) 1: 402-411.
56. Wu F, Zikusoka M, Trindade A, Dassopoulos T, Harris ML, et al. (2008) MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 135: 1624-1635.
57. Simone NL, Soule BP, Ly D, Saleh AD, Savage JE, et al. (2009) Ionizing radiation-induced oxidative stress alters miRNA expression. PLoS One 4: e6377.
58. Mathe E, Nguyen GH, Funamizu N, He P, Moake M, et al. (2011) Inflammation regulates microRNA expression in cooperation with p53 and nitric oxide. Int J Cancer. 10.1002/ijc.26403 [doi].
59. Weber M, Baker MB, Moore JP, Searles CD (2010) MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity. Biochem Biophys Res Commun 393: 643-648. S0006-291X(10)00256-1 [pii];10.1016/j.bbrc.2010.02.045 [doi].
60. Shin VY, Jin H, Ng EK, Cheng AS, Chong WW, et al. (2011) NF-kappaB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors. Carcinogenesis 32: 240-245. bgq240 [pii];10.1093/carcin/bgq240 [doi].
61. DeNicola GM, Tuveson DA (2009) RAS in cellular transformation and senescence. Eur J Cancer 45 Suppl 1: 211-216. S0959-8049(09)70036-X [pii];10.1016/S0959-8049(09)70036-X [doi].
62. Frezzetti D, Menna MD, Zoppoli P, Guerra C, Ferraro A, et al. (2011) Upregulation of miR-21 by Ras in vivo and its role in tumor growth. Oncogene 30: 275-286. onc2010416 [pii];10.1038/onc.2010.416 [doi].
63. Oliveira CJ, Schindler F, Ventura AM, Morais MS, Arai RJ, et al. (2003) Nitric oxide and cGMP activate the Ras-MAP kinase pathway-stimulating protein tyrosine phosphorylation in rabbit aortic endothelial cells. Free Radic Biol Med 35: 381-396. S0891584903003113 [pii].
64. Abraham C, Cho JH, (2009) Inflammatory bowel disease. N Engl J Med 361: 2066-2078.
65. McGovern DP, Gardet A, Torkvist L, Goyette P, Essers J, et al. (2010) Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet 42: 332-337.
66. Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, et al. (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 42: 1118-1125. ng.717 [pii];10.1038/ng.717 [doi].
67. Rivas MA, Beaudoin M, Gardet A, Stevens C, Sharma Y, et al. (2011) Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 43: 1066-1073. ng.952 [pii];10.1038/ng.952 [doi].
68. Hedl M, Li J, Cho JH, Abraham C, (2007) Chronic stimulation of Nod2 mediates tolerance to bacterial products. Proc Natl Acad Sci U S A 104: 19440-19445.
69. Maeda S, Hsu LC, Liu H, Bankston LA, Iimura M, et al. (2005) Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 307: 734-738.
70. Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, et al. (2011) Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479: 232-236. nature10600 [pii];10.1038/nature10600 [doi].